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Background: Per oral endoscopic myotomy (POEM) has been reported to be a new therapeutic option for
esophageal achalasia. The possibility that POEM could reduce the risk of developing esophageal squamous cell
carcinoma was evaluated.
Methods: This was a single-centre, retrospective study. Fifteen consecutive patients with esophageal achalasia who
underwent POEM in our institution between August 2010 and January 2012 were enrolled. Ultra-high magnification
with endocytoscopy was performed, and both histopathological and immunohistochemical evaluations for Ki-67
and p53 were assessed before and 3 months after POEM.
Results: POEM was successfully performed and effectively released the dysphagia symptom in all patients without
severe complications. Subjective symptoms (mean Ekcardt score, before 7.4 vs. after 0.5, p<0.05) and manometric
pressure studies (mean lower esophageal sphincter pressure), before 82.7 vs. after 22.9 mmHg, p<0.05) showed
substantial improvement following POEM. The average numbers of esophageal epithelial nuclei before and after
POEM on endocytoscopic images were 128.0 and 78.0, respectively (p<0.05). The mean Ki-67-positive ratio was 26.0
(median 25.4, range, 10.3-33.2) before and 20.7 (median 20.0, 13.1-29.9; p=0.07) after POEM, and the mean
p53-positive ratio was 2.35 (median 2.61, 0.32-4.23) before and 0.97 (median 1.49, 0.32-1.56; p<0.05) after POEM. A
significant positive correlation was seen between the number of nuclei and the Ki-67-positive ratio (p<0.05).
Conclusions: POEM appears to be an effective and less invasive treatment of choice against achalasia and may
reduce the risk of esophageal carcinogenesis. Endocytoscopy can be useful for the assessment of esophageal
cellular proliferation.
Keywords: Esophageal achalasia, POEM, Per-oral endoscopic myotomy, Esophageal cancer, Squamous cell
carcinoma* Correspondence: hajimei2002@yahoo.co.jp
1Department of Gastroenterology and Hepatology, Nagasaki University
Hospital, 1-7-1, Sakamoto, Nagasaki 852-8501, Japan
Full list of author information is available at the end of the article
© 2013 Minami et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Minami et al. BMC Gastroenterology 2013, 13:22 Page 2 of 9
http://www.biomedcentral.com/1471-230X/13/22Background
Achalasia is a rare, chronic, esophageal motility disorder
with an estimated annual prevalence of 1 per 100,000
subjects in Western populations [1]. The disease can
occur at all ages, but the incidence seems to increase
with age. The predominant symptoms are dysphagia and
regurgitation, because of the impaired relaxation of the
lower esophageal sphincter (LES) and the loss of normal
peristalsis [2]. Persistent esophageal distension with re-
tention of foods and fluids, bacterial overgrowth, and
impaired clearance of regurgitated acid and gastric con-
tents lead to chronic inflammation and passively cause
dysplasia and carcinoma [3-5]. The aim of therapy is to
reduce food stasis, which might interrupt the progres-
sion to carcinoma and thus reduce the risk of squamous
cell carcinoma. In 1872, Fagge reported the first case of
esophageal carcinoma developing in a patient with acha-
lasia [6]. The reported incidence of concomitant carcin-
oma and achalasia ranges from 0.53% to 8.6% [7]. In a
recent study, Meijssen et al. reported that the risk of
developing squamous cell carcinoma in achalasia
patients was increased 33-fold over that in the general
population [8]. Leeuwenburgh et al. also reported that
the relative hazard ratio of esophageal cancer was 28
(confidence interval 17–46) compared with an age- and
sex-identical population in the same timeframe [1]. Al-
though many investigators have warned clinicians about
the high incidence of carcinogenesis in achalasia [9], the
prognosis of patients who develop such carcinomas
remains poor.
Recently, per oral endoscopic myotomy (POEM) was
introduced by Inoue et al. [10] as a less invasive and ef-
fective curative treatment option with minimal compli-
cations. In the present study, the clinical feasibility of
POEM in achalasia patients in our hospital was evalu-
ated. In addition, whether this innovative procedure
could affect esophageal epithelial proliferation was
examined by ultra-high magnification with endocyto-
scopy, along with immunohistochemical staining of tar-
geted biopsies with antibody against Ki-67 nuclear
antigen before and after POEM. Immunohistochemistry
with anti-p53 antibody was also used to assess the alter-
ation in squamous cell carcinoma risk with POEM.
Methods
Design
This was a single-centre, retrospective study. This study
was approved by ethics committee of Nagasaki Univer-
sity Hospital.
Patients
Fifteen consecutive cases of esophageal achalasia which
underwent POEM in our institution between August
2010 and January 2012 were enrolled in this study. Aclinical summary of the 15 patients (3 males, 12 females;
mean age 51.7 years, age range 26–84 years) with
esophageal achalasia is shown in Table 1. The dilation
grade of the disease was II in 6 patients and III in 1 pa-
tient. Prior endoscopic balloon dilation was performed
in 5 patients. Two patients with sigmoid type achalasia
were included.
Written informed consent was obtained from all sub-
jects, a legal surrogate, the parents or legal guardians for
minor subjects prior to their inclusion, in accordance
with the Helsinki Declaration and under approval by the
Nagasaki University Ethics Committee. All the subjects
also consented for the publication of individual clinical
details with a written informed consent.
Dysphagia symptom scores
To evaluate improvement of dysphagia objectively, a
dysphagia symptom score and the Eckardt score (repre-
sentative subjective symptom score) were used [11].
The dysphagia symptom score was defined as follows:
the worst degree of dysphagia just before the treatment
was scored as 10, and the best condition, before the
patient developed achalasia, was scored as zero, in ac-
cordance with Inoue’s report [10]. The post-procedural
degree of dysphagia was scored between 0 and 10 in
each patient. Scoring was done before POEM, after
POEM on the day of discharge from hospital, and 3, 6,
and 12 months later.
Barium esophagogram
The degree and shape of achalasia were assessed by bar-
ium passage. The maximum diameter of the thoracic
esophagus was measured, and achalasia was classified
into grade I (diameter <3.5 cm), grade II (3.5 cm < diam-
eter < 6.0 cm), and grade III (diameter ≥6.0 cm), in ac-
cordance with the descriptive rules (Descriptive Rules
for Achalasia of the Esophagus, Japan Society of Esopha-
geal Diseases, June 2012, 4th Edition). On the day fol-
lowing POEM, a barium swallow was done to confirm
passage of contrast media through the gastroesophageal
junction (GEJ) without leakage. Achalasia shapes include
straight, flask, and sigmoid types.
Esophageal manometry
Esophageal pull-through manometry was done in all
cases before and after the procedure using the Polygraf
ID (Medtronic Functional Diagnostics, Denmark).
According to the manufacturer’s data, the normal range
for LES pressure with this device is from 14.3 to
34.5 mmHg. The manometry study could not be com-
pleted in case 15 before POEM because the measuring
catheter did not pass through the narrow segment of the
esophagus.
Table 1 Patients’ characteristics
No. Sex Age (years) BMI (kg/m2) Dilation Type Balloon dilation Systemic complication
1 female 60 20.3 II straight - none
2 female 50 17.1 II straight - none
3 male 54 21.9 III sigmoid 3 sessions hypertension
4 female 63 18.4 II sigmoid - breast cancer
5 female 45 23.2 I straight - rheumatoid arthritis
6 female 26 18.0 I straight - none
7 female 38 18.5 I straight - none
8 female 47 22.4 II straight 1 session none
9 female 84 26.5 I straight - hypertension
10 female 79 18.7 I straight 1 session pulmonary emphysema
11 male 43 22.4 I straight - none
12 male 69 17.0 I straight 5 sessions pulmonary emphysema
13 female 46 19.0 I straight 2 sessions none
14 female 37 21.8 II straight - none
15 female 38 25.4 II straight - none
maen 51.7 20.7
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The POEM procedure received approval from the insti-
tutional review board (IRB) of Nagasaki University Hos-
pital (approval number 10052824, issued on May, 22
2010). Written informed consent was obtained from all
patients.
A forward-viewing endoscope with an outer diameter
of 9.8 mm (GIF-H260; Olympus, Tokyo, Japan), which
is routinely used for upper gastrointestinal examination,
was used with a transparent distal cap attachment
(MH-588, Olympus). A triangle-tip knife (KD- 640 L;
Olympus) was used to dissect the submucosal layer and
to divide circular muscle bundles. A coagulating forceps
(Coagrasper, FD-411QR; Olympus) was used to coagu-
late larger vessels prior to dissection and for hemostasis.
The VIO 300D (ERBE, Tubingen, Germany) electroge-
nerator was used, and for final closure of the mucosal
entry site, hemostatic clips (EZ-CLIP, HX- 110QR; Olym-
pus) were applied. The procedures were performed under
general anesthesia with positive pressure ventilation. The
UCR CO2 insufflator (Olympus) was used with a regular
insufflating tube (MAJ-1742; Olympus), which maintained
CO2 insufflation at a constant rate of 1.2 L/min.
The POEM procedures were done as previously
described with slight modifications as follows. Submuco-
sal injection was done first at the level of the middle
thoracic esophagus, approximately 13 cm proximal to
the GEJ. About 10 mL of saline supplemented with 0.3%
indigocarmine were injected. A 2-cm, longitudinal mu-
cosal incision was made on the mucosal surface to create
a mucosal entry to the submucosal space (dry cut mode,
50 W, effect 3). Then, a technique similar to endoscopicsubmucosal dissection (ESD) was used to create a sub-
mucosal tunnel downwards, passing through the GEJ,
and about 3 cm into the proximal stomach (Figure 1a).
Spray coagulation mode (60 W, effect 2) was used to
dissect the submucosal layer. Larger vessels in the sub-
mucosa were coagulated using the forceps in the soft co-
agulation mode (80 W, effect 5). Dissection of the
circular muscle bundle was started at 2 cm distal from
the mucosal entry. The sharp tip of the knife was used
to capture only circular muscle bundles and then lift up
toward the tunnel lumen (Figure 1b). The captured cir-
cular muscle bundle was cut by spray coagulation
current (60 W, effect 2). Division of the sphincter
muscle was continued from the proximal side towards
the stomach until it passed 2 or 3 cm distal from the
LES. After completion of the myotomy, smooth passage
of the endoscope through the GEJ with minimal resist-
ance was confirmed. The incised mucosal entry was
closed with about five hemostatic clips after prophylactic
antibiotic solution was sprayed inside the tunnel. Suc-
cessful closure of the mucosal entry was confirmed by
the endoscopic appearance. At the end of the procedure,
the endoscope was again inserted into the original
esophageal lumen down to the stomach, to confirm
smooth passage through the GEJ.
Endocytoscopy
A prototype endocytoscope with an integrated dual
charge-coupled device (CCD) (Figure 2) (GIF-Y0001,
Olympus) was used. The dual-CCD integrated type
endoscope has both conventional magnification (80-fold)
and ultra-high magnification (450-fold) capabilities,
Figure 1 POEM procedures. 1-a. A long submucosal tunnel is created. The blue color of the indigocarmine that was mixed with the glycerin
solution helps discriminate the white muscle layer from submucosal tissue.1-b. Using a triangle-tip knife, the inner circular muscle is hooked and
cut. Outer longitudinal muscles are seen behind the inner muscles. Outer muscles should be preserved to avoid severe complications such as
compartment syndrome and mediastinitis.
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on the endoscope. The clinical use of the prototype
endoscope was approved by the hospital’s ethics com-
mittee (IRB approval number 10102236, Oct. 29 2010),
and written informed consent was obtained from all
patients. A mixture of 0.05% crystal violet and 0.1%
methylene blue was used during endocytoscopy to ob-
tain images similar to conventional pathological images
using hematoxylin and eosin staining. Crystal violet ef-
fectively dyes the cytoplasm, whereas methylene blue
allows detailed identification of the cell structure, includ-
ing the nuclei and cytoplasm. Dilution of methylene blue
with crystal violet seems to improve visualization of the
lesion and may also decrease the potential risk of DNA
damage due to a higher concentration of methylene blue
[12]. Patients underwent both conventional endoscopy
and endocytoscopy at the same time under conscious
sedation with intravenous pethidine hydrochlorideFigure 2 The dual-CCD endocytoscope carries lenses for both
conventional magnification and ultra-high magnification. This
scope enables us to obtain ultra-high magnifying images during
usual endoscopic examination.(35 mg; Opystan, Mitsubishi Tanabe Pharma, Osaka,
Japan), supplemented with diazepam (5–10 mg, Takeda
Pharmaceutical, Osaka, Japan). After conventional endo-
scopic observation, ultra-high magnification was applied.
The mucosa on the posterior wall 25 cm distal from the
incisor was targeted. Still images were obtained from the
targeted area, and 3 images of sufficient quality were
selected for evaluation. Then, the average nuclei counts of
the 3 images before and 3 months after POEM were com-
pared. After endocytoscopic observation, biopsies were
taken from the targeted area. All endocytoscopy examina-
tions were recorded, and the location photographed dur-
ing endocytoscopy coincided with the histopathological
images. Nevertheless, complete correspondence between
endocytoscopic images and microscopic images is still
limited [13].
Immunohistochemistry using anti-Ki-67 and anti-p53
antibodies
Four-mm tissue sections of the formalin-fixed, paraffin
wax-embedded samples were sliced and mounted on
silane-coated glass slides, dried, deparaffinized with xy-
lene and rehydrated through graded ethanol. Antigen re-
trieval was performed by boiling for 15 minutes in
10 mM monocitric acid buffer (pH 6.0) for anti-Ki-67
staining and in 10 mM Tris/ethylenediaminetetraacetic
acid buffer (pH 9.0) for anti-p53 staining. Prior to im-
mune staining, endogenous peroxidase activity was
blocked by incubating the slides in a 0.5% solution of
H2O2 in phosphate-buffered citric acid for 15 minutes at
room temperature. After washing 3 times with Tris-
buffered saline (TBS) with a pH of 7.4, the sections were
incubated in TBS buffer containing 10% rabbit non-
immune serum (DAKO, Glostrup, Denmark) and 10%
normal human plasma (and 5% bovine serum albumin
[BSA] for p53 staining) for 20 minutes. Then, the
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against anti-human Ki-67 antigen (clone MIB-1, DAKO)
in a 1:100 dilution or p53 antigen (clone DO-7, DAKO)
in a 1:100 dilution for 14 hours at 4°C. Subsequently,
biotin-labeled rabbit-anti-mouse antibody (DAKO) was
used as the second antibody, followed by the addition of
a streptavidin-horseradish peroxidase complex (DAKO).
To detect Ki-67 and p53, 3-amino-9-ethylcarbazole was
used as the substrate. One experienced pathologist who
was blinded to the clinical data counted at least 300 nu-
clei in each sample. Cells were counted as positive when
moderate to intense nuclear staining was found. Staining
with the isotype immunoglobulin and diluted solution
was performed in the same fashion for the negative
controls.
Statistics
Statistical analyses were performed using Fisher’s exact
test, the χ2 test, Student’s t-test, the Mann–Whitney U test,
and the Kruskal-Wallis test, as appropriate. A P value
<0.05 was accepted as significant. Data are expressed as
means ± standard deviation (SD).
Results
POEM
POEM was successfully performed in all 15 cases with-
out severe complications such as perforation and med-
iastinitis. Details of the procedure outcomes are shown
in Table 2. No massive pneumoperitoneum that required
reduction of abdominal distention or capnomediastinum







1 98 0 70.0 16.4
2 160 1 87.0 35.0
3 140 1 50.4 28.2
4 120 0 48.0 37.4
5 80 3 98.0 33.5
6 100 0 109.5 25.1
7 88 3 56.5 23.6
8 90 0 104.1 15.2
9 85 0 119.0 28.0
10 75 3 256.0 26.7
11 80 0 65.8 14.7
12 140 1 73.0 29.6
13 90 2 29.8 19.5
14 75 0 46.7 6.7
15 95 0 - 14.7
mean 101.1 0.7 82.7 22.9history and severe submucosal fibrosis due to preceding
repeat balloon dilation, experienced post-procedural
bleeding, which resolved with conservative management.
The mean LES pressure decreased from 82.7 to
22.9 mmHg, and the subjective symptom scores were also
significantly lower after POEM (Ekcardt score p < 0.05,
dysphagia symptom score p < 0.05).
Even after a mean follow-up of 11.3 (range 8 – 25)
months, no patient developed recurrent symptoms of
dysphagia. Endoscopic reflux esophagitis was identified
in 5 patients (33.3%) on follow-up endoscopy examin-
ation. Two (15.3%) patients received proton pump in-
hibitor (PPI) therapy, and the symptoms were easily
controlled.
Figure 3a-d shows the endoscopic images taken from
the GEJ and mid-thoracic esophagus before and after
POEM. Before POEM, the endoscope was passed
through the GEJ with great resistance. The thickened
esophageal mucosa showed turbidity and whitish color
change, lacking permeability of the vascular structures.
Following POEM, however, the resistance to endoscopic
passage through the GEJ was completely resolved, and
the mucosal abnormalities were substantially improved,
without the whitish color change. The POEM procedure
allowed detailed observation of the vascular structures
of the mucosal surface.
Endocytoscopic findings
Thirteen achalasia patients underwent endocytoscopy and
targeted biopsy before and after POEM. In Case 1, informed




3 0 14 none
8 1 15 none
3 0 15 bleedind(day 10)
8 0 13 none
7 1 12 none
9 0 15 none
7 3 18 none
9 0 14 none
5 0 15 none
6 1 10 none
9 1 18 none
8 1 18 bleedind(day 1)
4 1 15 none
6 0 17 none
12 0 14 none
7.4 0.5 14.9
Figure 3 Conventional endoscopic images of the EGJ and mid-thoracic esophagus before and after POEM. 3-a, b Before POEM, the EGJ is
extremely tight. Whitish color change is seen on the surface mucosa without permeability of vascular structures. 3-c, d After POEM, the narrow
segment of the EGJ has been totally released. The status of the surface mucosa is significantly improved, and permeability of the surface vascular
patterns is restored.
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adverse effects of methylene blue on her pregnancy.
The average counts of esophageal mucosal nuclei on
endocytoscopy before and 3 months after POEM were
128.0 (median 112.3, range 82.7-246.0) and 78.7 (median
76.0, 56.7-129.3) (Figure 4a), respectively. Thus, POEM
significantly reduced the number of nuclei (p < 0.005).
Compared to the endocytoscopic images obtained before
POEM, cellular and nuclear structures and inter-cellular
margins were observed more clearly in the images
obtained after POEM (Figure 5). The nuclei numbers be-
fore POEM varied very widely, whereas they were dis-
tributed in a relatively narrow range after the procedure.
There were no significant correlation between endo-
scopic nuclear counts and patients’ characteristics such
as degree of dilation, type, and duration of dysphagia
symptom. However, statistically significant correlation
between endocytoscopic nuclear counts and Eckardt
score before the procedure was observed (r = 0.7937,
0.3699 ~ 0.9441, p < 0.01).
The number of nuclei in 3 non-achalasia patients
(healthy controls) was also evaluated, and the averagecount was 88.5 (range, 76–97), which was the same
level as the post-POEM values in achalasia patients.Immunohistochemical analysis: Ki-67 and p53
immunostaining
The mean Ki-67-positive ratios before and after the
procedure were 26.0 (median 25.4, 10.3-33.2) and 20.7
(median 20.0, 13.1-29.9; p = 0.07), respectively (Figure 4b).
There was a significant positive correlation between the
esophageal epithelial nuclei numbers assessed by endocy-
toscopy and the Ki-67-positive ratios (correlation coeffi-
cient, 0.695, p < 0.05) (Figure 4d).
The p53-positive ratios were decreased in the post-
treatment group compared to the pre-treatment group
with statistical significance. The mean positive ratios
before and after the procedure were 2.35 (median 2.61,
0.32-4.23) and 0.97 (median 1.49, 0.32-1.56), respect-
ively (Figure 4c). Histopathological evaluation with
hematoxylin and eosin staining confirmed that all of
the specimens were negative for dysplasia or squamous
cell carcinoma.
Figure 4 a-d. The endocytoscopic counts of nuclei are significantly improved after POEM (a). Also, the mean Ki-67-positive ratios before
and after the procedure are 26.0 (median 25.4, 10.3-33.2) and 20.7 (median 20.0, 13.1-29.9), respectively (p = 0.07) (b, c). The mean p53-positive
ratios before and after the procedure are 2.35 (median 2.61, 0.32-4.23) and 0.97 (median 1.49, 0.32-1.56). There was a significant positive
correlation between the esophageal epithelial nuclei numbers assessed by endocytoscopy and the Ki-67-positive ratios (correlation coefficient,
0.695, p < 0.05) (Figure 4d).
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Recently, POEM has been developed in Japan [10] as a
less invasive and effective curative treatment option with
no cases of severe complications. Other therapeutic
options include endoscopic balloon dilatation and surgi-
cal myotomy. Endoscopic balloon dilatation is still
widely performed because of its relative noninvasiveness
and simplicity, but it has a relatively lower success rate
and often requires multiple treatment sessions [14].
Inoue et al. reported that there was no recurrence after
the POEM procedure in their 17 case series of achalasia
in their short-term results [10]. They also reported the
lack of recurrence on 43 patients of maximum of 1 year
9 months observation [15] (Japanese manuscript). In the
present 15 cases, no severe complications such asperforation and severe mediastinitis occurred, and the
clinical course was uneventful in each case. Although
the term has been relatively short, there has been no dis-
ease recurrence during the observation period. Surgical
myotomy has been thought to be the curative thera-
peutic choice for symptomatic achalasia. However, it
requires skin incisions and additional anti-reflux surgical
intervention. Thus, POEM could be one of the most
promising treatment options for symptomatic achalasia.
On the basis of prior data, the overall prevalence of
esophageal squamous cell carcinoma in patients with
achalasia has been estimated to be up to 8.6%, account-
ing for a 50-fold increase in cancer risk [7]. In achalasia
patients, it has been suggested that chronic food stasis
leads to chronic inflammation, epithelial hyperplasia,
Figure 5 Comparison of endocytoscopic images between before and after POEM, including the shape and size of cells and the
number of nuclei. The number of surface cells and cellular arrangement was significantly improved after POEM.
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(SCC) [1,16,17]. Previous studies showed that it would
take a mean of 24 (range 10–43) years to establish car-
cinoma after symptom onset, and 3 to 4 years for carcin-
oma to develop from dysplasia [1,18,19]. Goldblum et al.
noted that several epithelial abnormalities were seen in
achalasia, including high-grade squamous dysplasia,
superficial squamous cell carcinoma, and lymphocytic
esophagitis [20], exclusively accompanied by diffuse
squamous hyperplasia reflecting accelerated cellular
turnover and proliferation.
The changes in endocytoscopic images were examined
together with the cellular proliferative ability of the mu-
cosal surface in order to evaluate whether the POEM
procedure improved cellular proliferation as well as
mucosal inflammation. The ultra-high magnification
enables us to observe cellular irregularity, similar to con-
ventional pathological images [12,21]. Inoue et al.
reported that there was a significant correlation between
endocytoscopic images and histopathological images in
various gastrointestinal disorders [12,21]. As shown in
Figure 5, comparison of endocytoscopic images between
before and after POEM revealed significant improve-
ments in the nuclear counts and the irregularity of cellu-
lar arrangement. The endocytoscopic nuclear counts
after POEM reached almost the same levels as healthy
controls. The POEM procedure substantially reduced
Ki-67 positivity. There was a significant correlation be-
tween Ki-67 expression and endocytoscopic nuclear
counts (Figure 4d). Collectively, cellular proliferation
ability could be assessed by endocytoscopic images. At
the same time, endocytoscopy allows us to obtain infor-
mation about cellular atypia [12,21].
Fujii et al. reported cases of esophageal squamous cell
carcinoma concomitant with achalasia and found higher
Ki-67 positivity in cancer lesions than in non-cancerouslesions [22]. Leeuwenburgh evaluated the expressions of
both p53 and Ki-67 in achalasia patients and reported
that overexpression of p53 could be an early marker of
neoplastic progression in achalasia [23]. In esophageal
adenocarcinoma, Reid and Kerkhof reported that both
p53 and Ki-67 were effective for early discrimination
[24,25]. The present data showed decreases of both Ki-
67 and p53 expressions after POEM, which implies that
POEM could reduce the future risk of developing
esophageal squamous cell carcinoma.
Leeuwenburgh documented that Ki-67 expression was
not a discriminative factor for carcinogenesis in achalasia
patients. However, they targeted the GEJ, which could be
easily affected by distention of food and fermentation. Ex-
pression of the Ki-67 protein is associated with the clinical
course of cell proliferation that is closely linked to tissue
inflammation [26]. Leeuwenburgh and his colleagues sug-
gested taking a biopsy from the thoracic esophagus, not
from the EGJ, to avoid the effects of severe inflammation.
In the present series, biopsies were taken from the
middle-thoracic esophagus to avoid sampling severely
inflamed mucosa.
Furthermore, advanced achalasia may conceal the dys-
phagia caused by cancer growth. Stasis of the esophageal
contents and a severely inflamed mucosa make it almost
impossible to detect early cancers. Improving visualization
via the therapeutic intervention allows detailed observa-
tion and cancer inspection at an earlier stage. Therefore,
we strongly insist that early release of the obstruction is
essential for finding early cancers and preventing the
development of advanced cancer.
Brossard et al. showed that the incidence of squamous
cell carcinoma was eight times higher in untreated
patients with achalasia and 4.5 times higher in patients
treated with pneumatic dilatation than in those treated
with surgical myotomy [27]. Endoscopic myotomy may
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cess rate than other options. Endoscopic balloon dilata-
tion has a lower success rate [14] than the POEM
procedure. Unlike surgical myotomy, POEM allows us
to preserve the anatomical integrity of the LES and pos-
sibly minimize postoperative reflux [28,29]. Nevertheless,
these LES pressure-lowering therapies could be ultim-
ately complicated by the development of Barrett’s
esophagus and adenocarcinoma. Therefore, longer
follow-up is obviously necessary to clarify the risk of
Barrett’s cancer due to reflux esophagitis, which was
observed in some of our cases [19,30].
Conclusions
POEM could be one of the most effective and less inva-
sive treatment options against dysphagia and reduce the
risk of developing esophageal squamous cell carcinoma.
Endocytoscopy can be useful for the assessment of
esophageal cellular proliferation.
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